Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/16/25 16:30 | 10/15/25 | RAPP | Health | Drug | Pharmaceutical Preparations | Bredt David | MA | O | Chief Sc | 8 | S | -1,020 | 14.99 | 0 | -68 | 469 | D | |||||||||||||||
10/16/25 16:30 | 10/15/25 | RAPP | Health | Drug | Pharmaceutical Preparations | Ceesay Abraham | MA | DO | CEO | 2 | S | -2,293 | 26.25 | 0 | -87 | 713 | M | |||||||||||||||
9/10/25 16:15 | 9/8/25 | RAPP | Health | Drug | Pharmaceutical Preparations | Gault Cheryl | MA | O | COO | 1 | S.d | -192 | 38.33 | 0 | -5 | 172 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |